Hong Kong Regulations
[Index]
[Table]
[Search]
[Notes]
[Noteup]
[Previous]
[Next]
[Download (Current & Past)]
[Download (Current only)]
[繁體中文]
[Help]
CHINESE MEDICINES REGULATION - SECT 5
Licensing requirements in respect of applications made under section 132 of the Ordinance
For the purposes of section 132(2) of the Ordinance, the following are the
prescribed licensing requirements in respect of an application for a
manufacturer licence-
(a) the premises to which the application relates are in sanitary
condition;
(b) where ingredients or packing materials, or both, used for
manufacturing proprietary Chinese medicines are to be stored in the
premises-
(i) adequate space; and
(ii) adequate and suitable facilities, for storing the ingredients
or packing materials, or both, as the case may be, are provided
in the premises;
(c) where any Schedule 1 medicine is to be stored in the same premises
with any Schedule 2 medicine or material of herbal, animal or mineral
origin customarily used by the Chinese for medicinal purpose,
arrangements are made so that the Schedule 1 medicine can be stored
effectively separated from the Schedule 2 medicine or material;
(d) fittings and equipment suitable for use in the manufacturing process
specified in the application are provided in the premises;
(e) where intermediate products generated or proprietary Chinese medicines
manufactured in the course of manufacture, or both, are to be stored
in the premises-
(i) adequate space; and
(ii) adequate and suitable facilities, for storing the products or
medicines, or both, as the case may be, are provided in the
premises;
(f) the humidity, lighting, temperature and ventilation of the part of the
premises provided for-
(i) storing ingredients or packing materials;
(ii) manufacturing proprietary Chinese medicines; or
(iii) storing intermediate products or proprietary Chinese medicines,
are suitable for their respective purposes;
(g) the premises are in all other respects suitable for carrying on a
business in the manufacture of proprietary Chinese medicines; and
(h) each responsible person nominated in the application complies with the
minimum requirements regarding knowledge and experience as set out in
section 2 of Schedule 1.
[Index]
[Table]
[Search]
[Notes]
[Noteup]
[Previous]
[Next]
[Download (Current & Past)]
[Download (Current only)]
[繁體中文]
[Help]